Reply to M.C. Chamberlain

Affiliations

Comment

Martin J B Taphoorn. J Clin Oncol. 2016.

. 2016 Jan 20;34(3):292.

doi: 10.1200/JCO.2015.64.3072. Epub 2015 Nov 30.

¹ Medical Center Haaglanden, the Hague, and VU University Medical Center, Amsterdam, the Netherlands m.taphoorn@mchaaglanden.nl.

No abstract available

Comment on

Health-Related Quality of Life in a Randomized Phase III Study of Bevacizumab, Temozolomide, and Radiotherapy in Newly Diagnosed Glioblastoma.
Taphoorn MJ, Henriksson R, Bottomley A, Cloughesy T, Wick W, Mason WP, Saran F, Nishikawa R, Hilton M, Theodore-Oklota C, Ravelo A, Chinot OL. Taphoorn MJ, et al. J Clin Oncol. 2015 Jul 1;33(19):2166-75. doi: 10.1200/JCO.2014.60.3217. Epub 2015 May 26. J Clin Oncol. 2015. PMID: 26014298 Clinical Trial.
Similar Trials With Differing Outcomes: Reconciliation in Glioblastoma.
Chamberlain MC. Chamberlain MC. J Clin Oncol. 2016 Jan 20;34(3):291-2. doi: 10.1200/JCO.2015.64.1746. Epub 2015 Nov 30. J Clin Oncol. 2016. PMID: 26628477 No abstract available.